Johnson & Johnson announces final results of exchange offer, finalizes separation of Kenvue Johnson & Johnson has completed its Kenvue separation. Alembic makes executive appointmentNilesh Wadhwa, head of international business and strategy, has been designated as senior management personnel. Fresenius Kabi, Formycon secure U.S. license date for proposed Stelara biosimilar The proposed Stelara biosimilar is a human monoclonal antibody for treatment of immune-mediated disorders. Novartis spin-off of Sandoz generics drug unit to occur on or around Oct. 4 Novartis said it is confident that the spin-off is in the best interests of shareholders. Walmart makes leadership changes Sam’s Club’s chief executive Kathryn McLay has been promoted to head Walmart’s international business, succeeding Judith McKenna, who is retiring. Camber Pharmaceuticals Camber is rising to the challenges facing today’s marketplace with continuous supply, excellent customer service and an unwavering commitment to its partners and patients, the company said. Ahold Delhaize delivers solid Q2 results Growth in loyalty and online sales contributed to Ahold Delhaize's solid Q2 results. Upsher-Smith launches generic Accutane Isotretinoin capsules are indicated for severe recalcitrant nodular acne. Lupin obtains tentative nod from FDA for dolutegravir lamivudine and tenofovir alafenamide The tablet is used to treat HIV. Buoyed by higher prices, Haleon raises forecast According to a Financial Times report, Haleon reported better-than-expected sales on well-known products despite higher prices. First Previous 16 17 18 19 20 Next Last
